Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Evan Adelstein

Showing results (1-10 of 62) with videos related to

Pageof 7
Sort By:
Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing|November 28, 2016
Long-term use of the wearable cardioverter-defibrillator: prolonging life or prolonging indecision?Evan Adelstein
JACC. Clinical Electrophysiology|May 12, 2018
The Wearable Cardioverter-Defibrillation: An Investment Worth Making or Needing Further Investigation?Evan Adelstein, Samir Saba
American Heart Journal|December 18, 2007
Right atrial pacing and the risk of postimplant atrial fibrillation in cardiac resynchronization therapy recipientsEvan Adelstein, Samir Saba
Circulation. Heart Failure|September 20, 2012
The atria are fibrillating: does it matter to the resynchronized ventricles?Samir Saba, Evan Adelstein
Journal of the American College of Cardiology|February 12, 2008
Cardiac resynchronization therapy and atrial tachyarrhythmias: a question still searching for an answerEvan Adelstein, Samir Saba
Current Cardiology Reports|July 2, 2013
Targeting left ventricular lead placement to improve cardiac resynchronization therapy outcomesJeffrey Liu, Evan Adelstein, Samir Saba
Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing|April 15, 2010
Implantable cardioverter defibrillators confer survival benefit in patients with renal insufficiency but not in dialysis-dependent patientsFaris Khan, Evan Adelstein, Samir Saba
Clinical Cardiology|June 16, 2010
Beta-blocker utilization and outcomes in patients receiving cardiac resynchronization therapyAndrew Voigt, Alaa Shalaby, Evan Adelstein, et al.
Cardiology Research|March 31, 2017
Choice and Utility of Pacing Maneuver in Establishing the Mechanism of Supraventricular Tachycardia: A Single Center ExperienceSaddam Abisse, Evan Adelstein, Sandeep Jain, et al.
Journal of Cardiovascular Electrophysiology|February 22, 2011
Predicting hyperresponse among pacemaker-dependent nonischemic cardiomyopathy patients upgraded to cardiac resynchronizationEvan Adelstein, David Schwartzman, John Gorcsan, et al.
Pageof 7

Showing results (1-10 of 62) with videos related to

Sort By:
Pageof 7
Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing|November 28, 2016
Long-term use of the wearable cardioverter-defibrillator: prolonging life or prolonging indecision?Evan Adelstein
JACC. Clinical Electrophysiology|May 12, 2018
The Wearable Cardioverter-Defibrillation: An Investment Worth Making or Needing Further Investigation?Evan Adelstein, Samir Saba
American Heart Journal|December 18, 2007
Right atrial pacing and the risk of postimplant atrial fibrillation in cardiac resynchronization therapy recipientsEvan Adelstein, Samir Saba
Circulation. Heart Failure|September 20, 2012
The atria are fibrillating: does it matter to the resynchronized ventricles?Samir Saba, Evan Adelstein
Journal of the American College of Cardiology|February 12, 2008
Cardiac resynchronization therapy and atrial tachyarrhythmias: a question still searching for an answerEvan Adelstein, Samir Saba
Current Cardiology Reports|July 2, 2013
Targeting left ventricular lead placement to improve cardiac resynchronization therapy outcomesJeffrey Liu, Evan Adelstein, Samir Saba
Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing|April 15, 2010
Implantable cardioverter defibrillators confer survival benefit in patients with renal insufficiency but not in dialysis-dependent patientsFaris Khan, Evan Adelstein, Samir Saba
Clinical Cardiology|June 16, 2010
Beta-blocker utilization and outcomes in patients receiving cardiac resynchronization therapyAndrew Voigt, Alaa Shalaby, Evan Adelstein, et al.
Cardiology Research|March 31, 2017
Choice and Utility of Pacing Maneuver in Establishing the Mechanism of Supraventricular Tachycardia: A Single Center ExperienceSaddam Abisse, Evan Adelstein, Sandeep Jain, et al.
Journal of Cardiovascular Electrophysiology|February 22, 2011
Predicting hyperresponse among pacemaker-dependent nonischemic cardiomyopathy patients upgraded to cardiac resynchronizationEvan Adelstein, David Schwartzman, John Gorcsan, et al.
Pageof 7